{COPYRIGHT NASAL DELIVERY A NEW HOPE FOR LOW MOOD IN THE CONTINENT ?

The arrival of esketamine delivery system represents a groundbreaking change in the treatment of treatment-resistant depressive illness across European markets . While until recently requiring hospital-based administration, this option allows for a increased scope of individual accessibility , al